Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sotera Health (SHC) EBITDA: 2020-2025

Historic EBITDA for Sotera Health (SHC) over the last 6 years, with Sep 2025 value amounting to $31.2 million.

  • Sotera Health's EBITDA fell 17.46% to $31.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.5 million, marking a year-over-year decrease of 9.52%. This contributed to the annual value of -$71.2 million for FY2024, which is 208.91% down from last year.
  • Latest data reveals that Sotera Health reported EBITDA of $31.2 million as of Q3 2025, which was down 65.02% from $89.1 million recorded in Q2 2025.
  • In the past 5 years, Sotera Health's EBITDA registered a high of $89.1 million during Q2 2025, and its lowest value of -$262.4 million during Q4 2022.
  • For the 3-year period, Sotera Health's EBITDA averaged around $10.9 million, with its median value being $5.5 million (2025).
  • As far as peak fluctuations go, Sotera Health's EBITDA crashed by 3,159.33% in 2022, and later surged by 630.93% in 2025.
  • Over the past 5 years, Sotera Health's EBITDA (Quarterly) stood at $58.4 million in 2021, then crashed by 549.40% to -$262.4 million in 2022, then skyrocketed by 122.92% to $60.1 million in 2023, then slumped by 218.57% to -$71.3 million in 2024, then dropped by 17.46% to $31.2 million in 2025.
  • Its EBITDA was $31.2 million in Q3 2025, compared to $89.1 million in Q2 2025 and $5.5 million in Q1 2025.